Medicare Enrolled
Dr. Rafael Yakutilov, M.D.
Neurology · Rockaway Park, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yakutilov from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yakutilov?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yakutilov
Dr. Rafael Yakutilov is a neurology specialist in Rockaway Park, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Yakutilov performed 1,590 Medicare services across 1,178 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yakutilov received a total of $34,273 from 79 pharmaceutical and/or device companies across 1531 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yakutilov is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 21% volume in NY
$34,273 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,590
Medicare services
Top 21% in NY for neurology
1,178
Unique beneficiaries
$126
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~76 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
454 | $115 | $231 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
322 | $81 | $165 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
122 | $153 | $307 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
82 | $58 | $120 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
80 | $58 | $117 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
78 | $258 | $514 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
76 | $158 | $367 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
66 | $36 | $73 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
66 | $98 | $199 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
61 | $122 | $236 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
52 | $263 | $530 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
42 | $195 | $394 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
33 | $425 | $846 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
23 | $105 | $208 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
19 | $91 | $185 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
14 | $366 | $720 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$34,273
Total received (2018-2024)
Avg $4,896/year across 7 years
Top 14% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
1,531
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$34,019 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$225 (0.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$30 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,162
2023
$6,542
2022
$6,660
2021
$5,012
2020
$2,771
2019
$3,014
2018
$2,111
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$636
Amgen Inc.
$452
UCB, Inc.
$448
Neurelis, Inc.
$442
ACADIA Pharmaceuticals Inc
$399
HARMONY BIOSCIENCES LLC
$398
ANI Pharmaceuticals, Inc.
$386
SK Life Science, Inc.
$383
PFIZER INC.
$377
Mallinckrodt Hospital Products Inc.
$368
Alexion Pharmaceuticals, Inc.
$367
Otsuka America Pharmaceutical, Inc.
$347
Teva Pharmaceuticals USA, Inc.
$340
Neurocrine Biosciences, Inc.
$309
SCILEX PHARMACEUTICALS INC.
$303
Amneal Pharmaceuticals LLC
$284
Grifols USA, LLC
$207
Eisai Inc.
$200
Takeda Pharmaceuticals U.S.A., Inc.
$180
Sumitomo Pharma America, Inc.
$146
ARGENX US, INC.
$132
Novo Nordisk Inc
$124
Harmony Biosciences Llc
$120
Octapharma USA, Inc.
$114
Biogen, Inc.
$111
Kyowa Kirin, Inc.
$108
TG Therapeutics, Inc.
$99
Azurity Pharmaceuticals, Inc.
$81
Celgene Corporation
$76
CATALYST PHARMACEUTICALS, INC.
$55
EMD Serono, Inc.
$54
Lundbeck LLC
$45
Genentech USA, Inc.
$30
Paratek Pharmaceuticals, Inc.
$19
Vanda Pharmaceuticals Inc.
$17
Top 3 companies account for 18.8% of 2024 payments
All-time payments by company (2018-2024) ›
Neurocrine Biosciences, Inc.
$2,699
Teva Pharmaceuticals USA, Inc.
$2,288
UCB, Inc.
$1,900
ACADIA Pharmaceuticals Inc
$1,726
Biogen, Inc.
$1,702
SK Life Science, Inc.
$1,696
ABBVIE INC.
$1,295
Mallinckrodt Hospital Products Inc.
$1,189
Neurelis, Inc.
$1,137
Eisai Inc.
$996
AbbVie Inc.
$987
Allergan, Inc.
$811
Lundbeck LLC
$796
Avanir Pharmaceuticals, Inc.
$783
Sunovion Pharmaceuticals Inc.
$770
PFIZER INC.
$766
Otsuka America Pharmaceutical, Inc.
$737
Amgen Inc.
$726
Novartis Pharmaceuticals Corporation
$664
ANI Pharmaceuticals, Inc.
$558
Alexion Pharmaceuticals, Inc.
$541
Harmony Biosciences LLC
$492
EISAI INC.
$442
Vanda Pharmaceuticals Inc.
$433
ARGENX US, INC.
$423
HARMONY BIOSCIENCES LLC
$398
Biohaven Pharmaceuticals, Inc.
$398
E.R. Squibb & Sons, L.L.C.
$382
Lilly USA, LLC
$378
Celgene Corporation
$354
CATALYST PHARMACEUTICALS, INC.
$353
Sumitomo Pharma America, Inc.
$322
Mallinckrodt Enterprises LLC
$318
Amneal Pharmaceuticals LLC
$307
SCILEX PHARMACEUTICALS INC.
$303
Paratek Pharmaceuticals, Inc.
$298
Grifols USA, LLC
$228
Kyowa Kirin, Inc.
$221
Mallinckrodt LLC
$217
GENZYME CORPORATION
$205
ARBOR PHARMACEUTICALS, INC.
$200
TG THERAPEUTICS, INC.
$193
Takeda Pharmaceuticals U.S.A., Inc.
$180
IMPEL PHARMACEUTICALS INC.
$178
Daiichi Sankyo Inc.
$176
Janssen Pharmaceuticals, Inc
$156
Arbor Pharmaceuticals, Inc.
$129
Novo Nordisk Inc
$124
Harmony Biosciences Llc
$120
Octapharma USA, Inc.
$114
Horizon Therapeutics plc
$114
Acorda Therapeutics, Inc
$112
RedHill Biopharma Inc.
$109
Genentech USA, Inc.
$106
Azurity Pharmaceuticals, Inc.
$104
TG Therapeutics, Inc.
$99
Allergan Inc.
$98
Biohaven Pharmaceutical Holding Company Ltd.
$88
Almatica Pharma LLC
$86
AstraZeneca Pharmaceuticals LP
$64
EMD Serono, Inc.
$54
Smith+Nephew, Inc.
$44
Sentynl Therapeutics, Inc.
$31
Medtronic, Inc.
$30
Catalyst Pharmaceuticals, Inc.
$27
Averitas Pharma Inc.
$27
Bioventus LLC
$27
Smith & Nephew, Inc.
$24
Scilex Pharmaceuticals Inc.
$23
LivaNova USA, Inc.
$23
JAZZ PHARMACEUTICALS INC.
$23
Adamas Pharmaceuticals, Inc.
$23
Axsome Therapeutics, Inc.
$22
CSL Behring
$20
Merck Sharp & Dohme Corporation
$20
Akcea Therapeutics, Inc.
$19
Corium, LLC
$19
Purdue Pharma L.P.
$15
Shionogi Inc
$14
Top 3 companies account for 20.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · Auvelity · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COMIRNATY · CREXONT · Cenobamate · Dayvigo · ELIQUIS · EMGALITY · EPIDIOLEX · FANAPT · FIRDAPSE · Fycompa · GELSYN 3 · GILENYA · GOCOVRI · GRALISE · Gamunex-C · HETLIOZ · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KRYSTEXXA · Leqembi · Levorphanol Tartrate · MAYZENT · MIDAS REX · MOVANTIK · Morphabond ER · Movantik · NAPRELAN · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · NUZYRA · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · Ocrevus · Ongentys · PANZYGA · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUTENZA · REXULTI · REYVOW · RYTARY · SOLIRIS · SYMPROIC · Santyl · Symproic · TECFIDERA · TEGSEDI · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · Wegovy · XCOPRI · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
1,092
Per 100K population
46.9
County median income
$84,961
Nearest hospital
SOUTH BROOKLYN HEALTH
4.9 mi
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yakutilov is a clinical cardiology specialist, with above-average Medicare volume (top 21% in NY), with low-engagement industry engagement in the top 14% of NY peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yakutilov experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Yakutilov performed 454 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yakutilov receive payments from pharmaceutical companies?
Yes. Dr. Yakutilov received a total of $34,273 from 79 companies across 1,531 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yakutilov's costs compare to other neurologists in Rockaway Park?
Dr. Yakutilov's average Medicare payment per service is $126. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yakutilov) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Rockaway Park
Browse neurologists in Rockaway Park ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology